Fourth and final issue of GaBI Journal’s fourth volume
Bioequivalence of narrow therapeutic index drugs and immunosuppressives
Non-Biological Complex Drugs (NBCDs) and their follow-on versions: time for an editorial section
Challenges of developing generics substitution policies in low- and middle-income countries (LMICs)
Patent expiry dates for best-selling biologicals
Supporting biosimilarity and extrapolation
Measuring performance in off-patent drug markets
Immunogenicity assessment of monoclonal antibodies
Source URL: https://gabi-journal.net/20154-gabi-journal-table-of-contents.html
Copyright ©2024 GaBI Journal unless otherwise noted.